<?xml version="1.0" encoding="ISO-8859-1"?>
<?xml-stylesheet type="text/xsl" href="helma.xsl"?>
<xmlroot xmlns:hop="http://www.helma.org/docs/guide/features/database">
  <hopobject id="2432" name="Page" prototype="Page" created="1363280116832" lastModified="1542476913597">
  <hop:parent idref="0" prototyperef="Root"/>
    <http_browser>Mozilla/4.0 (compatible; MSIE 6.0; Windows NT 5.1; SV1)</http_browser>
    <lang>en-us</lang>
    <uri>bone-update</uri>
    <http_host>127.0.0.1:8080</http_host>
    <time type="date">17.11.2018 17:48:33 UTC</time>
    <pseudoparent idref="0" prototyperef="Root"/>
    <http_remotehost>127.0.0.1</http_remotehost>
    <hopsession>127.0.0.yn02qaw2ku7l</hopsession>
    <user>default</user>
    <pvcount type="float">85.0</pvcount>
    <body>I&apos;m about to run out of credit &lt;a href=&quot;http://kssgrp.com/stmap_54570.html?cialis.quetiapine.lanoxin.synthroid&quot;&gt;deer antler spray for sale&lt;/a&gt;  The Epicentre approach seeks to protect children from cerebral malariaâs most dangerous effect: a buildup of malaria parasites that causes inflammation and disrupts blood flow inside the brain. This buildup prevents the flow of oxygen to brain centers that control basic neurological function and even breathing, resulting in convulsions, coma, and eventually, death. Even as anti-malaria drugs such as artemisinins attack the parasites, the inflammation and blockage can still put the child in danger.
 </body>
    <http_language>en-US,en;q=0.8</http_language>
    <is_xhtml type="boolean">true</is_xhtml>
    <http_referer>http://beagleboard.org/bone-update/edit</http_referer>
  </hopobject>
</xmlroot>
